<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
SEC FILE NUMBER: 0-8241
CUSIP NUMBER: 068508100
NOTIFICATION OF LATE FILING
[X] FORM 10-KSB
FOR THE FISCAL YEAR ENDED: DECEMBER 31, 1997
If the notification relates to a portion of the filing checked above, identify
the items to which the notification relates:
PART I - REGISTRANT INFORMATION
Full name of Registrant: Barringer Laboratories, Inc.
Former Name if Applicable: N/A
Address of Principal Executive Office: 15000 West Sixth Avenue, Suite 300,
Golden, Colorado 80401
PART II -RULES 12B-25(b) AND (c)
The subject report could not be filed without unreasonable effort or expense and
the Registrant seeks relief pursuant to Rule 12b-25(b) because:
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense; and
(b) The subject annual report will be filed on or before the fifteenth
calendar day following the prescribed due date.
(c) The statement or other exhibit required by Rule 12b-25(c) has been
attached hereto.
PART III - NARRATIVE
Preparation of the information, including the financial statements, in the
Form 10-KSB has taken longer than originally anticipated. Hence, the Registrant
will be filling the Form 10-KSB after the scheduled due date. The Registrant
intends to file the Form 10-KSB as soon as practicable, but no more than 15 days
after the original due date.
<PAGE>
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Graham Russell, (303) 277-1687.
(2) Have all other periodic reports during the preceding 12 months (or for such
shorter period that the Registrant was required to file such reports) been
filed? [X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion
thereof? [X]Yes [ ]No
The Company experienced a net loss of approximately $312,000 for 1997
versus a net income in 1996 of approximately $736,000 primarily due to
higher costs of services sold, slightly higher general and administrative
costs and approximately $271,000 of non-recurring expenses.
- --------------------------------------------------------------------------------
BARRINGER LABORATORIES, INC.
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 31, 1998 By: /s/ Graham Russell
--------------------------------
Graham Russell, President
